TEMSIROLIMUS
| Brand name | TORISEL |
|---|---|
| Active ingredient | TEMSIROLIMUS |
| Strength | 25MG/ML (25MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | May 2007 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8791097*PED | November 2032 | — |
| 8791097 | May 2032 | use U-1550 |
| 8026276*PED | July 2026 | — |
| 8026276 | January 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.